MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis
NYSE:MPW - New York Stock Exchange, Inc. - US58463J3041 - REIT - Currency: USD
Taking everything into account, MPW scores 2 out of 10 in our fundamental rating. MPW was compared to 129 industry peers in the Diversified REITs industry. MPW has a bad profitability rating. Also its financial health evaluation is rather negative. MPW is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year MPW has reported negative net income.
MPW had a positive operating cash flow in the past year.
Of the past 5 years MPW 4 years were profitable.
In the past 5 years MPW always reported a positive cash flow from operatings.
1.2 Ratios
MPW has a worse Return On Assets (-17.48%) than 96.83% of its industry peers.
MPW's Return On Equity of -48.96% is on the low side compared to the rest of the industry. MPW is outperformed by 93.65% of its industry peers.
With a Return On Invested Capital value of 0.14%, MPW is not doing good in the industry: 90.48% of the companies in the same industry are doing better.
MPW had an Average Return On Invested Capital over the past 3 years of 2.90%. This is in line with the industry average of 3.11%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.48% | ||
| ROE | -48.96% | ||
| ROIC | 0.14% |
ROA(3y)1.57%
ROA(5y)1.97%
ROE(3y)3.64%
ROE(5y)4.41%
ROIC(3y)2.9%
ROIC(5y)3.2%
1.3 Margins
MPW has a Operating Margin of 3.91%. This is amonst the worse of the industry: MPW underperforms 89.68% of its industry peers.
In the last couple of years the Operating Margin of MPW has declined.
Looking at the Gross Margin, with a value of 96.76%, MPW belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
In the last couple of years the Gross Margin of MPW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.91% | ||
| PM (TTM) | N/A | ||
| GM | 96.76% |
OM growth 3Y-48%
OM growth 5Y-33.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.88%
GM growth 5Y-0.6%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MPW is destroying value.
The number of shares outstanding for MPW has been increased compared to 1 year ago.
MPW has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MPW is higher compared to a year ago.
2.2 Solvency
MPW has an Altman-Z score of -0.04. This is a bad value and indicates that MPW is not financially healthy and even has some risk of bankruptcy.
MPW's Altman-Z score of -0.04 is on the low side compared to the rest of the industry. MPW is outperformed by 80.95% of its industry peers.
MPW has a debt to FCF ratio of 90.96. This is a negative value and a sign of low solvency as MPW would need 90.96 years to pay back of all of its debts.
MPW's Debt to FCF ratio of 90.96 is in line compared to the rest of the industry. MPW outperforms 50.00% of its industry peers.
MPW has a Debt/Equity ratio of 1.69. This is a high value indicating a heavy dependency on external financing.
MPW has a Debt to Equity ratio of 1.69. This is in the lower half of the industry: MPW underperforms 67.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.69 | ||
| Debt/FCF | 90.96 | ||
| Altman-Z | -0.04 |
ROIC/WACC0.03
WACC5.37%
2.3 Liquidity
A Current Ratio of 1.73 indicates that MPW should not have too much problems paying its short term obligations.
The Current ratio of MPW (1.73) is better than 70.63% of its industry peers.
MPW has a Quick Ratio of 1.73. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MPW (1.73) is better than 73.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.73 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
The earnings per share for MPW have decreased strongly by -2428.57% in the last year.
Measured over the past years, MPW shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.94% on average per year.
Looking at the last year, MPW shows a very negative growth in Revenue. The Revenue has decreased by -53.35% in the last year.
Measured over the past years, MPW shows a small growth in Revenue. The Revenue has been growing by 2.13% on average per year.
EPS 1Y (TTM)-2428.57%
EPS 3Y-24.4%
EPS 5Y-18.94%
EPS Q2Q%-805.26%
Revenue 1Y (TTM)-53.35%
Revenue growth 3Y-11.3%
Revenue growth 5Y2.13%
Sales Q2Q%-26.34%
3.2 Future
The Earnings Per Share is expected to decrease by -27.04% on average over the next years. This is quite bad
The Revenue is expected to decrease by -5.36% on average over the next years.
EPS Next Y-1014.19%
EPS Next 2Y-45.69%
EPS Next 3Y-27.04%
EPS Next 5YN/A
Revenue Next Year-24.77%
Revenue Next 2Y-16.46%
Revenue Next 3Y-9.43%
Revenue Next 5Y-5.36%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
MPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MPW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MPW is valued expensively inside the industry as 91.27% of the companies are valued cheaper.
MPW's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MPW is cheaper than 69.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.79 | ||
| EV/EBITDA | 23.87 |
4.3 Compensation for Growth
MPW's earnings are expected to decrease with -27.04% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.69%
EPS Next 3Y-27.04%
5. Dividend
5.1 Amount
MPW has a Yearly Dividend Yield of 6.81%, which is a nice return.
MPW's Dividend Yield is a higher than the industry average which is at 18.20.
Compared to an average S&P500 Dividend Yield of 2.27, MPW pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.81% |
5.2 History
The dividend of MPW has a limited annual growth rate of 0.77%.
MPW has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.77%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
MPW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-13.67%
EPS Next 2Y-45.69%
EPS Next 3Y-27.04%
MEDICAL PROPERTIES TRUST INC
NYSE:MPW (1/31/2025, 8:04:00 PM)
After market: 4.68 -0.01 (-0.21%)4.69
-0.01 (-0.21%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners65.56%
Inst Owner Change-0.08%
Ins Owners7.35%
Ins Owner Change-1.66%
Market Cap2.82B
Analysts51.58
Price Target4.65 (-0.85%)
Short Float %44.26%
Short Ratio17.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.81% |
Yearly Dividend1.03
Dividend Growth(5Y)0.77%
DP-13.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1582.66%
Min EPS beat(2)-2512.24%
Max EPS beat(2)-653.07%
EPS beat(4)1
Avg EPS beat(4)-703.86%
Min EPS beat(4)-2512.24%
Max EPS beat(4)536.49%
EPS beat(8)1
Avg EPS beat(8)-401.52%
EPS beat(12)5
Avg EPS beat(12)-244.5%
EPS beat(16)7
Avg EPS beat(16)-186.59%
Revenue beat(2)1
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-9.56%
Max Revenue beat(2)5.9%
Revenue beat(4)2
Avg Revenue beat(4)0.19%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)7.24%
Revenue beat(8)3
Avg Revenue beat(8)-1.63%
Revenue beat(12)4
Avg Revenue beat(12)-2.08%
Revenue beat(16)6
Avg Revenue beat(16)-1.17%
PT rev (1m)-5.19%
PT rev (3m)-8.75%
EPS NQ rev (1m)-269.41%
EPS NQ rev (3m)-178.54%
EPS NY rev (1m)-19.85%
EPS NY rev (3m)-84.19%
Revenue NQ rev (1m)-8.35%
Revenue NQ rev (3m)-6.2%
Revenue NY rev (1m)-2.59%
Revenue NY rev (3m)-4.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.39 | ||
| P/FCF | 27.79 | ||
| P/OCF | 9.26 | ||
| P/B | 0.52 | ||
| P/tB | 0.52 | ||
| EV/EBITDA | 23.87 |
EPS(TTM)-1.77
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.17
FCFY3.6%
OCF(TTM)0.51
OCFY10.8%
SpS1.07
BVpS9.06
TBVpS9.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.48% | ||
| ROE | -48.96% | ||
| ROCE | 0.17% | ||
| ROIC | 0.14% | ||
| ROICexc | 0.14% | ||
| ROICexgc | 0.14% | ||
| OM | 3.91% | ||
| PM (TTM) | N/A | ||
| GM | 96.76% | ||
| FCFM | 15.8% |
ROA(3y)1.57%
ROA(5y)1.97%
ROE(3y)3.64%
ROE(5y)4.41%
ROIC(3y)2.9%
ROIC(5y)3.2%
ROICexc(3y)2.96%
ROICexc(5y)3.34%
ROICexgc(3y)3.03%
ROICexgc(5y)3.41%
ROCE(3y)3.68%
ROCE(5y)4.05%
ROICexcg growth 3Y-55.38%
ROICexcg growth 5Y-43.02%
ROICexc growth 3Y-55.51%
ROICexc growth 5Y-42.22%
OM growth 3Y-48%
OM growth 5Y-33.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.88%
GM growth 5Y-0.6%
F-Score3
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.69 | ||
| Debt/FCF | 90.96 | ||
| Debt/EBITDA | 18.71 | ||
| Cap/Depr | 43.4% | ||
| Cap/Sales | 31.63% | ||
| Interest Coverage | 0.06 | ||
| Cash Conversion | 61.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.73 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | -0.04 |
F-Score3
WACC5.37%
ROIC/WACC0.03
Cap/Depr(3y)699.06%
Cap/Depr(5y)1326.09%
Cap/Sales(3y)161.44%
Cap/Sales(5y)274.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2428.57%
EPS 3Y-24.4%
EPS 5Y-18.94%
EPS Q2Q%-805.26%
EPS Next Y-1014.19%
EPS Next 2Y-45.69%
EPS Next 3Y-27.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-53.35%
Revenue growth 3Y-11.3%
Revenue growth 5Y2.13%
Sales Q2Q%-26.34%
Revenue Next Year-24.77%
Revenue Next 2Y-16.46%
Revenue Next 3Y-9.43%
Revenue Next 5Y-5.36%
EBIT growth 1Y-95.54%
EBIT growth 3Y-53.88%
EBIT growth 5Y-32.07%
EBIT Next Year71.29%
EBIT Next 3Y16.65%
EBIT Next 5Y13.88%
FCF growth 1Y107.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.6%
OCF growth 3Y-6.44%
OCF growth 5Y2.41%